Identification of functional modules that correlate with phenotypic difference: The influence of network topology

Genome Biology

Volumn 11, Issue 2, 2010, Pages

  Hung, Jui Hung ^a   Whitfield, Troy W ^b   Yang, Tun Hsiang ^a   Hu, Zhenjun ^a,c   Weng, Zhiping ^a,b,c   DeLisi, Charles ^a,c  

^a BOSTON UNIVERSITY   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c Boston University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; GONADORELIN; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; STAT PROTEIN;

AEROBIC METABOLISM; APOPTOSIS; ARTICLE; BIOINFORMATICS; CARCINOGENESIS; COLORECTAL CANCER; FATTY ACID METABOLISM; HUMAN; INTERMETHOD COMPARISON; LUNG SMALL CELL CANCER; PHENOTYPE; PHENOTYPIC VARIATION; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; ADENOMA; BIOLOGY; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC DATABASE; GENETICS; GENOTYPE; LUNG TUMOR; METHODOLOGY;

ADENOMA; COLORECTAL NEOPLASMS; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENOTYPE; HUMANS; LUNG NEOPLASMS; PHENOTYPE; SMALL CELL LUNG CARCINOMA;

EID: 77949365759     PISSN: 14747596     EISSN: 1474760X     Source Type: Journal    
DOI: 10.1186/gb-2010-11-2-r23     Document Type: Article

References (86)

1. Goeman JJ, Buhlmann P. Analyzing gene expression data in terms of gene sets: methodological issues. Bioinformatics 2007, 23:980-987.
2. Eichler GS, Reimers M, Kane D, Weinstein JN. The LeFE algorithm: embracing the complexity of gene expression in the interpretation of microarray data. Genome Biol 2007, 8:R187. 2375025, 17845722.
3. Fujita A, Gomes LR, Sato JR, Yamaguchi R, Thomaz CE, Sogayar MC, Miyano S. Multivariate gene expression analysis reveals functional connectivity changes between normal/tumoral prostates. BMC Syst Biol 2008, 2:106. 2628381, 19055846.
4. Pavlidis P, Lewis DP, Noble WS. Exploring gene expression data with class scores. Pac Symp Biocomput 2002, 474-485.
5. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003, 34:267-273.
6. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005, 102:15545-15550. 1239896, 16199517.
7. Rahnenfuhrer J, Domingues FS, Maydt J, Lengauer T. Calculating the statistical significance of changes in pathway activity from gene expression data. Stat Appl Genet Mol Biol 2004, 3:Article16. 16646794.
8. Liu M, Liberzon A, Kong SW, Lai WR, Park PJ, Kohane IS, Kasif S. Network-based analysis of affected biological processes in type 2 diabetes models. PLoS Genet 2007, 3:e96. 1904360, 17571924.
9. Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C, Georgescu C, Romero R. A systems biology approach for pathway level analysis. Genome Res 2007, 17:1537-1545. 1987343, 17785539.
10. Dittrich MT, Klau GW, Rosenwald A, Dandekar T, Muller T. Identifying functional modules in protein-protein interaction networks: an integrated exact approach. Bioinformatics 2008, 24:i223-231. 2718639, 18586718.
11. Ulitsky I, Shamir R. Detecting pathways transcriptionally correlated with clinical parameters. Comput Syst Bioinformatics Conf 2008, 7:249-258.
12. Keller A, Backes C, Gerasch A, Kaufmann M, Kohlbacher O, Meese E, Lenhof HP. A novel algorithm for detecting differentially regulated paths based on gene set enrichment analysis. Bioinformatics 2009, 25:2787-2794. 2781748, 19713416.
13. Ackermann M, Strimmer K. A general modular framework for gene set enrichment analysis. BMC Bioinformatics 2009, 10:47. 2661051, 19192285.
14. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4:P3.
15. Gene Expression Omnibus (GEO). , http://www.ncbi.nlm.nih.gov/geo/
16. Hong Y, Ho KS, Eu KW, Cheah PY. A susceptibility gene set for early onset colorectal cancer that integrates diverse signaling pathways: implication for tumorigenesis. Clin Cancer Res 2007, 13:1107-1114.
17. Moxley R, Day E, Brown K, Mahnke M, Zurini M, Schmitz R, Jones CE, Jarai G. Cloning and pharmacological characterization of CCR7, CCL21 and CCL19 from Macaca fascicularis . Eur J Pharm Sci 2009, 37:264-271.
18. Yu S, Duan J, Zhou Z, Pang Q, Wuyang J, Liu T, He X, Xinfa L, Chen Y. A critical role of CCR7 in invasiveness and metastasis of SW620 colon cancer cell in vitro and in vivo. Cancer Biol Ther 2008, 7:1037-1043.
19. Pechlivanis S, Bermejo JL, Pardini B, Naccarati A, Vodickova L, Novotny J, Hemminki K, Vodicka P, Forsti A. Genetic variation in adipokine genes and risk of colorectal cancer. Eur J Endocrinol 2009, 160:933-940.
20. Monjazeb AM, High KP, Connoy A, Hart LS, Koumenis C, Chilton FH. Arachidonic acid-induced gene expression in colon cancer cells. Carcinogenesis 2006, 27:1950-1960.
21. Wu S, Moomaw CR, Tomer KB, Falck JR, Zeldin DC. Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. J Biol Chem 1996, 271:3460-3468.
22. Spector AA, Fang X, Snyder GD, Weintraub NL. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. Prog Lipid Res 2004, 43:55-90.
23. Jiang JG, Chen CL, Card JW, Yang S, Chen JX, Fu XN, Ning YG, Xiao X, Zeldin DC, Wang DW. Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors. Cancer Res 2005, 65:4707-4715.
24. Arakawa H. Netrin-1 and its receptors in tumorigenesis. Nat Rev Cancer 2004, 4:978-987.
25. Arakawa H. p53, apoptosis and axon-guidance molecules. Cell Death Differ 2005, 12:1057-1065.
26. Narayan G, Goparaju C, Arias-Pulido H, Kaufmann AM, Schneider A, Durst M, Mansukhani M, Pothuri B, Murty VV. Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression. Mol Cancer 2006, 5:16. 1482714, 16700909.
27. Dallol A, Morton D, Maher ER, Latif F. SLIT2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells. Cancer Res 2003, 63:1054-1058.
28. Grone J, Doebler O, Loddenkemper C, Hotz B, Buhr HJ, Bhargava S. Robo1/Robo4: differential expression of angiogenic markers in colorectal cancer. Oncol Rep 2006, 15:1437-1443.
29. Li VS, Yuen ST, Chan TL, Yan HH, Law WL, Yeung BH, Chan AS, Tsui WY, So S, Chen X, Leung SY. Frequent inactivation of axon guidance molecule RGMA in human colon cancer through genetic and epigenetic mechanisms. Gastroenterology 2009, 137:176-187.
30. Chedotal A, Kerjan G, Moreau-Fauvarque C. The brain within the tumor: new roles for axon guidance molecules in cancers. Cell Death Differ 2005, 12:1044-1056.
31. Cortina C, Palomo-Ponce S, Iglesias M, Fernandez-Masip JL, Vivancos A, Whissell G, Huma M, Peiro N, Gallego L, Jonkheer S, Davy A, Lloreta J, Sancho E, Batlle E. EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells. Nat Genet 2007, 39:1376-1383.
32. Miao H, Wei BR, Peehl DM, Li Q, Alexandrou T, Schelling JR, Rhim JS, Sedor JR, Burnett E, Wang B. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway. Nat Cell Biol 2001, 3:527-530.
33. Linghu B, Snitkin ES, Hu Z, Xia Y, Delisi C. Genome-wide prioritization of disease genes and identification of disease-disease associations from an integrated human functional linkage network. Genome Biol 2009, 10:R91. 2768980, 19728866.
34. Hileman EA, Achanta G, Huang P. Superoxide dismutase: an emerging target for cancer therapeutics. Expert Opin Ther Targets 2001, 5:697-710.
35. Jones MH, Virtanen C, Honjoh D, Miyoshi T, Satoh Y, Okumura S, Nakagawa K, Nomura H, Ishikawa Y. Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles. Lancet 2004, 363:775-781.
36. Akimoto M, Mishra K, Lim KT, Tani N, Hisanaga SI, Katagiri T, Elson A, Mizuno K, Yakura H. Protein tyrosine phosphatase epsilon is a negative regulator of FcepsilonRI-mediated mast cell responses. Scand J Immunol 2009, 69:401-411.
37. Kopec A, Panaszek B, Fal AM. Intracellular signaling pathways in IgE-dependent mast cell activation. Arch Immunol Ther Exp (Warsz) 2006, 54:393-401.
38. Galli SJ, Grimbaldeston M, Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 2008, 8:478-486.
39. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009, 30:1073-1081.
40. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008, 454:436-444.
41. Sparmann A, Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 2004, 6:447-458.
42. Sumimoto H, Imabayashi F, Iwata T, Kawakami Y. The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells. J Exp Med 2006, 203:1651-1656. 2118331, 16801397.
43. Harrison GS, Wierman ME, Nett TM, Glode LM. Gonadotropin-releasing hormone and its receptor in normal and malignant cells. Endocr Relat Cancer 2004, 11:725-748.
44. Gropp C, Luster W, Havemann K. Ectopic hormones in lung cancer. Ergeb Inn Med Kinderheilkd 1984, 53:133-164.
45. Taggart DP, Gray CE, Bowman A, Faichney A, Davidson KG. Serum androgens and gonadotrophins in bronchial carcinoma. Respir Med 1993, 87:455-460.
46. Blackman MR, Weintraub BD, Rosen SW, Harman SM. Comparison of the effects of lung cancer, benign lung disease, and normal aging on pituitary-gonadal function in men. J Clin Endocrinol Metab 1988, 66:88-95.
47. Park JI, Strock CJ, Ball DW, Nelkin BD. The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway. Mol Cell Biol 2003, 23:543-554. 151536, 12509453.
48. Ravi RK, Weber E, McMahon M, Williams JR, Baylin S, Mal A, Harter ML, Dillehay LE, Claudio PP, Giordano A, Nelkin BD, Mabry M. Activated Raf-1 causes growth arrest in human small cell lung cancer cells. J Clin Invest 1998, 101:153-159. 508551, 9421477.
49. Ravi RK, Thiagalingam A, Weber E, McMahon M, Nelkin BD, Mabry M. Raf-1 causes growth suppression and alteration of neuroendocrine markers in DMS53 human small-cell lung cancer cells. Am J Respir Cell Mol Biol 1999, 20:543-549.
50. Nilsson M, Unden AB, Krause D, Malmqwist U, Raza K, Zaphiropoulos PG, Toftgard R. Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1. Proc Natl Acad Sci USA 2000, 97:3438-3443. 16258, 10725363.
51. Ruiz i Altaba A, Sanchez P, Dahmane N. Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat Rev Cancer 2002, 2:361-372.
52. Chikkamuniyappa S. Coexisting basal cell carcinoma and metastatic small cell carcinoma of lung. Dermatol Online J 2004, 10:18.
53. Hever A, Roth RB, Hevezi P, Marin ME, Acosta JA, Acosta H, Rojas J, Herrera R, Grigoriadis D, White E, Conlon PJ, Maki RA, Zlotnik A. Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator. Proc Natl Acad Sci USA 2007, 104:12451-12456. 1941489, 17640886.
54. Ungethuem U, Häupl T, Koczan D, Huber H, von Helversen T, Ruiz P, Witt H, Drungowski M, Zacher HJ, Seyfert C, Neidel J, Krenn V, Burmester GR, Thiesen HJ, Lehrach H, Bläß S. RA-specific expression profiles and new candidate genes. Arthritis Res Ther 2003, 5(Suppl 1):81.
55. Lesnick TG, Papapetropoulos S, Mash DC, Ffrench-Mullen J, Shehadeh L, de Andrade M, Henley JR, Rocca WA, Ahlskog JE, Maraganore DM. A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet 2007, 3:e98. 1904362, 17571925.
56. Lebovic DI, Mueller MD, Taylor RN. Immunobiology of endometriosis. Fertil Steril 2001, 75:1-10.
57. Kao LC, Germeyer A, Tulac S, Lobo S, Yang JP, Taylor RN, Osteen K, Lessey BA, Giudice LC. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology 2003, 144:2870-2881.
58. Watterson K, Sankala H, Milstien S, Spiegel S. Pleiotropic actions of sphingosine-1-phosphate. Prog Lipid Res 2003, 42:344-357.
59. Lebre MC, Tak PP. Dendritic cells in rheumatoid arthritis: Which subset should be used as a tool to induce tolerance?. Hum Immunol 2009, 70:321-324.
60. Yasuhara T, Shingo T, Muraoka K, Kameda M, Agari T, Wen Ji Y, Hayase H, Hamada H, Borlongan CV, Date I. Neurorescue effects of VEGF on a rat model of Parkinson's disease. Brain Res 2005, 1053:10-18.
61. Hartman J, Garvik B, Hartwell L. Principles for the buffering of genetic variation. Science 2001, 291:1001-1004.
62. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J, Silliman N, Szabo S, Dezso Z, Ustyanksky V, Nikolskaya T, Nikolsky Y, Karchin R, Wilson PA, Kaminker JS, Zhang Z, Croshaw R, Willis J, Dawson D, Shipitsin M, Willson JK, Sukumar S, Polyak K, Park BH, Pethiyagoda CL, Pant PV, et al. The genomic landscapes of human breast and colorectal cancers. Science 2007, 318:1108-1113.
63. Kinzler BVKW. Cancer genes and the pathways they control. Nature Medicine 2004, 789-799.
64. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T, Yamanishi Y. KEGG for linking genomes to life and the environment. Nucleic Acids Res 2008, 36:D480-484. 2238879, 18077471.
65. KGML (KEGG Markup Language). , http://www.genome.jp/kegg/xml/
66. Floyd RW. Algorithm 97: Shortest path. Commun ACM 1962, 5:345.
67. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001, 125:279-284.
68. Hu Z, Ng DM, Yamada T, Chen C, Kawashima S, Mellor J, Linghu B, Kanehisa M, Stuart JM, DeLisi C. VisANT 3.0: new modules for pathway visualization, editing, prediction and construction. Nucleic Acids Res 2007, 35:W625-632. 1933155, 17586824.
69. PWEA. , http://zlab.bu.edu/PWEA/
70. Dongarra JJ, Kacsuk P, Podhorszki N. Recent Advances in Parallel Virtual Machine and Message Passing Interface: 7th European PVM/MPI Users' Group Meeting, Balatonfured, Hungary, September 2000 Proceedings 2000, Berlin, New York: Springer, Dongarra J, Kacsuk P, Podhorszki N, [Goos G, Hartmanis J, van Leeuwen J (Series Editors): Lecture Notes in Computer Science, volume 1908].
71. visANT. , http://visant.bu.edu/
72. Neoptolemos JP, Husband D, Imray C, Rowley S, Lawson N. Arachidonic acid and docosahexaenoic acid are increased in human colorectal cancer. Gut 1991, 32:278-281. 1378834, 1826490.
73. Ye YN, Wu WK, Shin VY, Cho CH. A mechanistic study of colon cancer growth promoted by cigarette smoke extract. Eur J Pharmacol 2005, 519:52-57.
74. Wong HP, Yu L, Lam EK, Tai EK, Wu WK, Cho CH. Nicotine promotes colon tumor growth and angiogenesis through beta-adrenergic activation. Toxicol Sci 2007, 97:279-287.
75. Rodriguez-Antona C, Ingelman-Sundberg M. Cytochrome P450 pharmacogenetics and cancer. Oncogene 2006, 25:1679-1691.
76. Denkert C, Budczies J, Weichert W, Wohlgemuth G, Scholz M, Kind T, Niesporek S, Noske A, Buckendahl A, Dietel M, Fiehn O. Metabolite profiling of human colon carcinoma-deregulation of TCA cycle and amino acid turnover. Mol Cancer 2008, 7:72. 2569965, 18799019.
77. Tocchi A, Basso L, Costa G, Lepre L, Liotta G, Mazzoni G, Sita A, Tagliacozzo S. Is there a causal connection between bile acids and colorectal cancer?. Surg Today 1996, 26:101-104.
78. Bernstein C, Bernstein H, Garewal H, Dinning P, Jabi R, Sampliner RE, McCuskey MK, Panda M, Roe DJ, L'Heureux L, Payne C. A bile acid-induced apoptosis assay for colon cancer risk and associated quality control studies. Cancer Res 1999, 59:2353-2357.
79. Emons G, Weiss S, Ortmann O, Grundker C, Schulz KD. LHRH might act as a negative autocrine regulator of proliferation of human ovarian cancer. Eur J Endocrinol 2000, 142:665-670.
80. Yonemori K, Kunitoh H, Sekine I. Small-cell lung cancer with lymphadenopathy in an 18-year-old female nonsmoker. Nat Clin Pract Oncol 2006, 3:399-403. quiz following 403..
81. Boonstra R, Timmer-Bosscha H, van Echten-Arends J, Kolk DM, Berg A, de Jong B, Tew KD, Poppema S, de Vries EG. Mitoxantrone resistance in a small cell lung cancer cell line is associated with ABCA2 upregulation. Br J Cancer 2004, 90:2411-2417. 2409533, 15150577.
82. Carney DN, Gazdar AF, Bepler G, Guccion JG, Marangos PJ, Moody TW, Zweig MH, Minna JD. Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res 1985, 45:2913-2923.
83. Onganer PU, Seckl MJ, Djamgoz MB. Neuronal characteristics of small-cell lung cancer. Br J Cancer 2005, 93:1197-1201. 2361510, 16265346.
84. Cao Y, Pearman AT, Zimmerman GA, McIntyre TM, Prescott SM. Intracellular unesterified arachidonic acid signals apoptosis. Proc Natl Acad Sci USA 2000, 97:11280-11285. 17191, 11005842.
85. Mashima T, Seimiya H, Tsuruo T. De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br J Cancer 2009, 100:1369-1372.
86. Kitami T, Nadeau JH. Biochemical networking contributes more to genetic buffering inhuman and mouse metabolic pathways than does gene duplication. Nat Genet 2002, 32:191-194.